Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
News PureTech licenses 'bacterial cocktail' to boost cancer immun... PureTech Health is to develop a combination of a microbiome treatment with checkpoint inhibitor immunotherapy to enhance the effect of the cancer drugs.
News Rebiotix microbiome drug success against C diff infection Patients suffering from a recurrent C diff infection have benefited from Rebiotix's microbiome treatment.
News UK spin-out Microbiotica wants to be world leader in microbi... Spin-out will exploit Sanger Institute expertise
News Novartis and J&J part of new US microbiome initiative The White House has launched a new national initiative focused on researching the microbiome with input from Novartis, Johnson & Johnson and others.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.